Company news

Biotron Limited news in 2018

Biotron Limited's news releases, calls and decks from 2018, newest first.

View company

Presentation of BIT225-009 HIV-1 Phase 2 data

November 28, 2018

Response to ASX aware letter

October 30, 2018

Biotron Secures $4.7 Million Underwriting Agreement

October 16, 2018

$1.07 million R&D Tax Incentive Received

October 14, 2018

Significant Immunological Outcomes in BIT225 HIV-1 Trial

September 28, 2018

Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial

August 7, 2018

Response to ASX Appendix 4C Query

May 10, 2018

Decks in 2018